Editorial
Published on 15 Feb 2023
Editorial: Pharmacokinetics, pharmacodynamics (PK/PD) of antibiotics: A reality check
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1150472
- 1,618 views
Type at least 3 characters
922 articles
Articles
Original Research
Published on 13 Feb 2023
Diagnosis potential of subarachnoid hemorrhage using miRNA signatures isolated from plasma-derived extracellular vesicles
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1090389
- 2,334 views
- 9 citations
Original Research
Published on 19 Jan 2023
Dual viscosity mixture vehicle for intratympanic steroid treatment modifies the ROS and inflammation related proteomes
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2023.1081724
- 2,206 views
- 1 citation
Clinical Trial
Published on 17 Jan 2023
SDI-118, a novel procognitive SV2A modulator: First-in-human randomized controlled trial including PET/fMRI assessment of target engagement
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1066447
- 3,212 views
- 5 citations
Original Research
Published on 12 Jan 2023
Insights in the maturational processes influencing hydrocortisone pharmacokinetics in congenital adrenal hyperplasia patients using a middle-out approach
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1090554
- 2,283 views
- 3 citations
Brief Research Report
Published on 11 Jan 2023
Management of diabetes mellitus in people living with HIV: A single-center experience
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1082992
- 1,638 views
- 2 citations
Review
Published on 09 Jan 2023
Drug-induced thrombotic microangiopathy: An updated review of causative drugs, pathophysiology, and management
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1088031
- 12,747 views
- 29 citations
Original Research
Published on 09 Jan 2023
Mapping knowledge landscapes and emerging trends of sonodynamic therapy: A bibliometric and visualized study
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1048211
- 4,296 views
- 22 citations
Review
Published on 06 Jan 2023
Hypothermia combined with neuroprotective adjuvants shortens the duration of hospitalization in infants with hypoxic ischemic encephalopathy: Meta-analysis
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1037131
- 3,130 views
- 9 citations
Review
Published on 04 Jan 2023
Clinical review of humic acid as an antiviral: Leadup to translational applications in clinical humeomics
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1018904
- 8,179 views
- 10 citations
Original Research
Published on 15 Dec 2022
Deep learning-based multi-drug synergy prediction model for individually tailored anti-cancer therapies
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1032875
- 4,994 views
- 11 citations
Editorial
Published on 13 Dec 2022
Editorial: Application of artificial intelligence in improving immunotherapeutic efficacy
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1100837
- 1,383 views
Original Research
Published on 13 Dec 2022
Viral delivery of a peptide-based immunomodulator enhances T cell priming during vaccination
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1029636
- 3,344 views
Editorial
Published on 12 Dec 2022
Editorial: Model-informed drug development and evidence-based translational pharmacology
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1086551
- 3,646 views
- 1 citation
Methods
Published on 08 Dec 2022
Induction of whole-body gene deletion via R26-regulated tamoxifen-inducible Cre recombinase activity
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1018798
- 10,505 views
- 1 citation
Original Research
Published on 01 Dec 2022
A mechanistic physiologically based model to assess the effect of study design and modified physiology on formulation safe space for virtual bioequivalence of dermatological drug products
in Translational Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2022.1007496
- 2,675 views
- 6 citations